PA
LABP
Perceptive Advisors’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,486,991
| Closed | -$31.9M | – | 127 |
|
|
2024
Q1 | $31.9M | Hold |
1,486,991
| – | – | 0.56% | 52 |
|
|
2023
Q4 | $5.44M | Hold |
1,486,991
| – | – | 0.12% | 75 |
|
|
2023
Q3 | $5.77M | Hold |
1,486,991
| – | – | 0.19% | 67 |
|
|
2023
Q2 | $6.26M | Sell |
1,486,991
-13,382,924
| -90% | -$4 | 0.18% | 72 |
|
|
2023
Q1 | $4.43M | Hold |
14,869,915
| – | – | 0.13% | 76 |
|
|
2022
Q4 | $7.43M | Hold |
14,869,915
| – | – | 0.21% | 63 |
|
|
2022
Q3 | $9.67M | Hold |
14,869,915
| – | – | 0.28% | 67 |
|
|
2022
Q2 | $10.8M | Hold |
14,869,915
| – | – | 0.34% | 59 |
|
|
2022
Q1 | $21.9M | Hold |
14,869,915
| – | – | 0.44% | 54 |
|
|
2021
Q4 | $71.4M | Hold |
14,869,915
| – | – | 1.1% | 23 |
|
|
2021
Q3 | $217M | Hold |
14,869,915
| – | – | 3.15% | 7 |
|
|
2021
Q2 | $172M | Hold |
14,869,915
| – | – | 2.23% | 10 |
|
|
2021
Q1 | $141M | Buy |
+14,869,915
| New | +$141M | 1.78% | 13 |
|